【摘要】 目的观察丹鹿胶囊治疗乳腺增生的疗效和安全性。方法将2016年1~3月在哈尔滨医科大学附属第二医院就诊的120例乳腺增生患者随机分成3组,每组40例,分别给予逍遥丸、三苯氧胺、丹鹿胶囊治疗,治疗疗程均为3个月。比较各组间的疗效及不良反应发生情况。结果逍遥丸组、三苯氧胺组、丹鹿胶囊组的治疗总有效率分别是60.0%、92.5%和87.5%,三苯氧胺组和丹鹿胶囊组总有效率明显高于逍遥丸组(P<0.05),三苯氧胺组和丹鹿胶囊组总有效率比较差异无显著性(P>0.05);逍遥丸组、三苯氧胺组、丹鹿胶囊组的不良反应发生率分别为2.5%、22.5%和5.0%,逍遥丸组和丹鹿胶囊组不良反应发生率明显低于三苯氧胺组(P<0.05),逍遥丸组和丹鹿胶囊组不良反应发生率比较差异无显著性(P>0.05)。结论丹鹿胶囊治疗乳腺增生的临床疗效较高,不良反应较少。更多还原

【Abstract】 Objective It is to observe the clinical effects and safety of Danlu capsule. Method 120 cases of patients with mammary hyperplasia were divided into 3 groups randomly: group Xiaoyao, group TAM and group Danlu, which were treated with Xiaoyao pill, TAM and Danlu capsule respectively. All the treatment courses were 3 months. The clinical effects and adverse reactions were compared in all the groups. Result The total effective rates of group Xiaoyao, group TAM and group Danlu were 60.0%, 92.5% and 87.5% respectively, and the rates of group TAM and group Danlu were significantly higher than that of group Xiaoyao(P<0.05), but there was no significant difference in the rate between group TAM and group Danlu(P>0.05). The occurrence rates of adverse reactions of group Xiaoyao, group TAM and group Danlu were 2.5%, 22.5% and 5.0% respectively, and the rates of adverse reactions of group Xiaoyao and group Danlu were significantly lower than group TAM(P<0.05), but there was no significant difference in the rate between group Xiaoyao and group Danlu(P> 0.05). Conclusion Danlu capsule is more effective in mammary hyperplasia and less adverse reactions.更多还原